Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy (Q34606479)

3 August 2017

Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy (English)

1 reference

3 August 2017

0 references

0 references

11

Howard L Kaufman

1 reference

3 August 2017

10

Francesco M Marincola

1 reference

3 August 2017

Marianna Sabatino

1

1 reference

3 August 2017

Seunghee Kim-Schulze

2

1 reference

3 August 2017

Monica C Panelli

3

1 reference

3 August 2017

David Stroncek

4

1 reference

3 August 2017

Ena Wang

5

1 reference

3 August 2017

Bret Taback

6

1 reference

3 August 2017

Dae Won Kim

7

1 reference

3 August 2017

Gail Deraffele

8

1 reference

3 August 2017

Zoltan Pos

9

1 reference

3 August 2017

language of work or name

English

0 references

publication date

13 April 2009

1 reference

Journal of Clinical Oncology

3 August 2017

1 reference

3 August 2017

27

1 reference

3 August 2017

16

1 reference

3 August 2017

2645-2652

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

3 August 2017

1 reference

Gene expression signatures of interleukin-2 in vivo and in vitro and their relation to anticancer therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Overexpression of vascular endothelial growth factor 189 in breast cancer cells leads to delayed tumor uptake with dilated intratumoral vessels

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Single-agent interleukin-2 in the treatment of metastatic melanoma: a systematic review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Update on the application of interleukin-2 in the treatment of renal cell carcinoma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Detection of human MCP-4/CCL13 isoforms by SELDI immunoaffinity capture

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Lessons from phase III clinical trials on anti-VEGF therapy for cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Inflammatory protein profile during systemic high dose interleukin-2 administration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

The pathway to biomarker discovery: carbonic anhydrase IX and the prediction of immune responsiveness

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

VEGF-integrin interplay controls tumor growth and vascularization.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Forecasting the cytokine storm following systemic interleukin (IL)-2 administration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Application of IL-2 and other cytokines in renal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Systematic variation in gene expression patterns in human cancer cell lines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Tumor angiogenesis: therapeutic implications

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

The development of new immunotherapies for the treatment of cancer using interleukin-2. A review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanoma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Breaking down the barriers to cancer immunotherapy

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2689845

Multiple correlations and Bonferroni's correction

9 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19364969

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19364969

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19364969

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1200/JCO.2008.19.1106

1 reference

3 August 2017

1 reference

3 August 2017

1 reference